An IL-15 superagonist shows promise
Results based on early data from clinical trial
Research supported by a recent $3.16 million NCI grant
Lenvatinib promising, trials ongoing
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New meta-analysis helps resolve the controversy
Proof-of-concept trial enrolling soon at Cleveland Clinic
More takeaways from the Biologic Therapies VI Summit